Kaposi sarcoma (KS) is a rare disease, and there is no specific treatment protocol agreed upon, especially for the classical type. Chemotherapeutics such as paclitaxel, pegylated liposomal doxorubicin (PLD), etoposide, gemcitabine are used in the […]
The group of authors from Affiliated Zhongda Hospital of Southeast University performed a study on the upper tract urothelial carcinoma. In their study, the authors sought to explore the incidence trends of upper tract urothelial […]
Background The research on the molecular pathology of pancreatic cancer (PCC) has not been in-depth enough, and there is a lack of comprehensive analysis of the transcriptomics and clinical characteristics of the disease to determine […]
Cancer is a condition in which the cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Furthermore, cancer is among […]
An accurate preoperative diagnosis of parotid tumors is essential for selection and planning of the surgical treatment, used in the most cases of parotid tumors. Many previous studies have shown that the modern cross-sectional imaging […]
Background Renal cell carcinoma (RCC) represents the 15th most common cancer worldwide. About 20% of patients with renal cell carcinoma eventually develop liver metastasis (LM). Furthermore, the liver is the only site of distant spread […]
Kazakhstan is a country in Central Asia with a high rate of gastric cancer. The development of gastric cancer is predisposed by a combination of genetic and environmental factors including dietary habits. With the advance […]
Despite the numerous developments in the diagnosis and treatment of gastric cancer, it continues to be an important public health problem. Therefore, besides classical methods, the new biomolecules are needed to facilitate the prediction of […]
Le et al. recently reported (Science 10.1126/science.aan6733 (2017); (ClinicalTrials.gov number, NCT01876511) on the success of immune checkpoint blockade with anti-PD-1 antibodies in the patients whose cancers exhibited microsatellite instability-high (MSI-H) status. The study included 12 […]
Targeted therapy based on the immune checkpoint inhibitors (Anti-PD1/PD-L1) has revolutionized cancer treatment and outcome of several solid and hematologic malignancies, including non-small cell lung carcinoma (NSCLC), metastatic renal cell carcinoma, metastatic malignant melanoma, advanced/metastatic […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH